US EditionPublished • loading... • Updated
Merck Price Prediction: Sac-TMT Drug Potential Pushes MRK to $150
Summary by 247wallst.com
1 Articles
1 Articles
Merck Price Prediction: Sac-TMT Drug Potential Pushes MRK to $150
Quick Read Wells Fargo raised its Merck price target to $150, betting that sac-TMT’s potential to displace chemotherapy across multiple cancer indications, combined with KEYTRUDA’s continued growth and a deepening pipeline of 80 Phase 3 studies, will drive a pipeline-driven rerating through 2026. Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today. Each …
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
